Abiopharma

🔍 COXE TENCH (Director)

Company: NVIDIA CORP (NVDA)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 1,211 shares of Common (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,378.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 25,671,360.00 | Footnotes: F2
• Holds 0 shares of Common (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Profit Sharing Plan Trust | shares_owned_after: 4,852,480.00 | Footnotes: F3

Footnotes:

• F1: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.
• F2: Shares held by a trust of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in the trust.
• F3: Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the Reporting Person.
• REMARKS: Exhibit 24 - Power of Attorney.